Reviews on new drug targets in age-related disorders. Part II / Paul C. Guest, editor.
Guest, Paul C., editor.
2021
RM301.63
Available Online

Linked e-resources

Linked Resource Online Access
Concurrent users Unlimited
Authorized users Authorized users
Document Delivery Supplied Can lend chapters, not whole ebooks

Details

Title Reviews on new drug targets in age-related disorders. Part II / Paul C. Guest, editor.
ISBN 9783030550356 (electronic bk.)
3030550354 (electronic bk.)
9783030550363 (print)
3030550362
3030550346
9783030550349
DOI https://doi.org/10.1007/978-3-030-55035-6
Imprint Cham : Springer, 2021.
Language English
Description 1 online resource
Other Standard Identifiers 10.1007/978-3-030-55035-6 doi
Call Number RM301.63
Dewey Decimal Classification 615.1/9
Summary Aging is an inevitable part of life, and is becoming a worldwide social, economic and health problem due to the fact that an increasing proportion of individuals in the advanced age category have a higher probability of developing age-related disorders. New therapeutic approaches are still in need to decrease or slow the effects of such diseases in this aging society. Advances in 'omic technologies such as genomics, transcriptomics, proteomics and metabolomics have significantly advanced our understanding of diseases in multiple medical areas. It is hoped that emerging hits from these analyses might be prioritized for further screening as potential novel drug targets for increasing the human healthspan in line with the lifespan, which will in turn lead to new therapeutic strategies and drug development projects by the pharmaceutical industry. This new book presents a series of reviews describing studies which have resulted in the identification of potential new drug targets for age-related disorders. Much of this information has come from 'omic comparisons of healthy and disease states or from testing the effects of potential new therapeutic approaches. Each chapter will be presented in the context of specific chronic diseases or different therapeutic strategies, providing important information on disease mechanisms related to the aging process. This book will be of interest to researchers in the areas of aging and chronic disease, as well as clinical scientists, physicians, and major drug companies. With contributors from Australia, Brazil, Canada, France, Germany, India, Iran, Iraq, South Africa, South Korea, Thailand, Ukraine, United Kingdom, United States of America, Uruguay and Vietnam, this is a timely follow up to Guest's previous book Reviews on New Drug Targets in Age-Related Disorders.
Note Includes index.
Access Note Access limited to authorized users.
Digital File Characteristics text file
PDF
Source of Description Online resource; title from PDF title page (SpringerLink, viewed April 5, 2021).
Added Author Guest, Paul C., editor.
Series Advances in experimental medicine and biology ; v. 1286. 2730-6216
Advances in experimental medicine and biology. Proteomics, metabolomics, interactomics and systems biology.
Available in Other Form Reviews on new drug targets in age-related disorders. Part II.
Linked Resources Online Access
Record Appears in Online Resources > Ebooks
All Resources
New Therapeutic Approaches and Biomarkers for Increased Healthspan
Targeting Cancer Metabolism and Current Anti-Cancer Drugs
A Review of Monoclonal Antibody-based Treatments in Non-small Cell Lung Cancer
Parkinson's Disease and Impairment in Mitochondrial Metabolism: A Pathognomic Signature
Targeted Treatment of Age-related Fibromyalgia with Supplemental Coenzyme Q10
Immunoregulatory Effects of Tolerogenic Probiotics in Multiple Sclerosis
Multifaceted Roles of Long Non-coding RNAs in Head and Neck Cancer
A Systematic Review on the Genotoxic Effects of Selective Serotonin Reuptake Inhibitors
Towards a New Era for the Management of Circulating Tumor Cells
Telomerase: A target for Therapeutic Effects of Curcumin in Cancer
Aspirin as a Potential Geroprotector: Experimental Data and Clinical Evidence
Targeting Stem Cells in Chronic Inflammatory Diseases
Therapeutic Strategies and Nano-drug Delivery Applications in Management of Aging Alzheimer's Disease
Psychometric Evaluation of Stress in 17,414 Critical Care Unit Nurses: Effects of Age, Gender and Working Conditions
Targeting Age-related Neurodegenerative Diseases by AAV Mediated Gene Therapy
Is Adipose Tissue the Fountain of Youth? The impact of Adipose Atem Cell Aging on Metabolic Homeostasis, Longevity and Cell-Based Therapies
Proteomics for Target Identification in Psychiatric and Neurodegenerative Disorders
Index.

Browse Subjects

Show more subjects...

Statistics

from
to
Export